Correlation Between Mereo BioPharma and IShares Dow

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and IShares Dow at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and IShares Dow into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and iShares Dow Jones, you can compare the effects of market volatilities on Mereo BioPharma and IShares Dow and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of IShares Dow. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and IShares Dow.

Diversification Opportunities for Mereo BioPharma and IShares Dow

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Mereo and IShares is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and iShares Dow Jones in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Dow Jones and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with IShares Dow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Dow Jones has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and IShares Dow go up and down completely randomly.

Pair Corralation between Mereo BioPharma and IShares Dow

Assuming the 90 days trading horizon Mereo BioPharma Group is expected to generate 7.29 times more return on investment than IShares Dow. However, Mereo BioPharma is 7.29 times more volatile than iShares Dow Jones. It trades about 0.08 of its potential returns per unit of risk. iShares Dow Jones is currently generating about 0.08 per unit of risk. If you would invest  79.00  in Mereo BioPharma Group on September 3, 2024 and sell it today you would earn a total of  276.00  from holding Mereo BioPharma Group or generate 349.37% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy94.38%
ValuesDaily Returns

Mereo BioPharma Group  vs.  iShares Dow Jones

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
iShares Dow Jones 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Dow Jones are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, IShares Dow is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Mereo BioPharma and IShares Dow Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and IShares Dow

The main advantage of trading using opposite Mereo BioPharma and IShares Dow positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, IShares Dow can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Dow will offset losses from the drop in IShares Dow's long position.
The idea behind Mereo BioPharma Group and iShares Dow Jones pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.